Sequential cyclophosphamide-bortezomib-dexamethasone (CyBorD) unmasks the harmful cardiac effect of dexamethasone in primary (AL) cardiac amyloidosis
29 April 2017 (08:30 - 17:30)
Organised by:
Abstract
About the speaker
University Hospital Henri Mondor, Creteil (France)
29 More presentations in this session
Access the full session
The Event
Heart Failure 2017 - 4th World Congress on Acute Heart Failure
29 April 2017
08:30 CET
